← Back to All Filings

Natera CEO Steven Chapman Sells $545K in Routine 10b5-1 Trade

Low SignificanceSeptember 3, 2026 at 9:07:15 PM EDT

Natera, Inc.

$NTRA4CIK: 0001604821

Subscribe to track NTRA

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Natera CEO Steven Chapman Sells $545K in Routine 10b5-1 Trade

Company: Natera, Inc. (NTRA) Form: 4 | Filed: 2026/09/04 Significance: Low

Insider: Chapman Steven Leonard Title: CEO AND PRESIDENT | Relationship: Director, Officer

Transaction: • Type: Sale • Shares: 1,698 • Price: $320.99 • Value: $545,041.02 • Owned After: 98,199

Key Insight: Routine Rule 10b5-1 scheduled disposition representing ~1.7% of the CEO's holdings and a negligible fraction of shares outstanding.

Market Context: NTRA trades at a large-cap valuation ($47.18B), making this transaction immaterial to overall float and company operations.

Comprehensive Analysis

SEC Filing Analysis: Natera, Inc. (NTRA)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: CEO Steven Chapman disposed of 1,698 shares for approximately $545K under a pre-established Rule 10b5-1 trading plan.
  • Market Impact: Neutral; immaterial transaction relative to company capitalization and shares outstanding.

Company Information

FieldValue
CompanyNatera, Inc.
Ticker SymbolNTRA
CIK0001604821
IndustryServices-Medical Laboratories [8071]

Insider Information

FieldValue
NameChapman Steven Leonard
CIK0001711968
Title/PositionCEO AND PRESIDENT
RelationshipDirector, Officer

Transaction Details

FieldValue
Form Type4
Transaction Date2026-09-01
Transaction CodeS (Open Market Sale)
Security TypeCommon Stock
Shares Involved1,698
Price Per Share$320.99
Total Value$545,041.02
Shares Owned After98,199
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$545,041.02
% of Market Cap0.0012%
Shares Transacted1,698
% of Shares Outstanding0.0012%
Post-Transaction Ownership98,199 shares (0.0686% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a large-cap issuer with a $47.18 billion market capitalization, a $545K transaction represents a negligible portion (<0.01%) of total value.
  • Ownership Concentration: The insider retains 98,199 direct shares, selling only ~1.7% of his direct position.
  • Dilution Impact: Non-dilutive secondary market disposition.
  • Transaction Significance: Low significance given the small transaction size relative to total shares outstanding and execution via an automated trading plan.

Market Impact Analysis

  • Stock Impact Prediction: Neutral. Pre-planned scheduled sales of minor magnitude rarely affect price discovery.
  • Expected Volume Impact: Immaterial compared to average daily trading volume.
  • Sentiment Indicator: Neutral.

Additional Context

  • Special Circumstances: The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2023, and last amended on March 5, 2026.
Topics:#SECFiling#NTRA#Form4#InsiderTrading#InsiderSell#StockAlert#Biotech#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.